Company / Assets per Share
Immunovant, Inc. Assets per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.40
FY2024
5-year range
$1.25 / $4.40
FY2020-FY2024
Trend
+49.6%
vs FY2023
Sector context
#159 of 212
Health Care
What the data says
Immunovant, Inc.'s assets per share of $4.40 is lower than 75% of companies in the Health Care sector (FY2024). Improved from $4.19 to $4.40 over the past 2 years.
Based on SEC 10-K filings.
4.40 in FY2024 with a 5-year CAGR of +68.9%.
Improved from $4.19 to $4.40 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- +68.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 212This company $4.40 Sector average $294.36
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 49.6% year-over-year.
- Ranks #159 out of 212 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $4.40 | +49.6% |
| FY2023 | $2.94 | -29.8% |
| FY2022 | $4.19 | +11.4% |
| FY2021 | $3.76 | +201.7% |
| FY2020 | $1.25 | +289.4% |
| FY2019 | $0.32 | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026